Dr. Kasem Charnvitayapong, MD

Dr. Charnvitayapong practices at Pulmonary & Internal Medicine Associates Inc in Stuart, Florida.

Dr. Charnvitayapong's NPI, 1497847206, was assigned on September 29, 2006. Dr. Charnvitayapong graduated from Creighton University School of Medicine - Omaha in 1990. Dr. Charnvitayapong holds Florida license ME0073266.

Dr. Charnvitayapong's primary practice is Pulmonary & Internal Medicine Associates Inc, at 2221 SE Ocean Blvd, Stuart, FL 34996 in Martin County. The practice phone is (772) 283-4428.

Dr. Charnvitayapong's primary practice is Pulmonary & Internal Medicine Associates Inc in Stuart, Florida. Dr. Charnvitayapong is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Pulmonary & Internal Medicine Associates. Dmand AI also links Dr. Charnvitayapong to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Charnvitayapong practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Charnvitayapong's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Charnvitayapong is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Charnvitayapong's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists acute sinusitis, asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia and lung resection among the conditions Dr. Charnvitayapong treats.

CMS data shows 12,488 Medicare services from Dr. Charnvitayapong across 28 procedure codes in 2024, for 1,367 Medicare patients. Medicare paid $721,114 for them.

CMS counts 1,367 Medicare patients who saw Dr. Charnvitayapong in 2024. The largest group is 75 to 84, with 589 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Charnvitayapong's median patient age at 76, with 54% women.

In 2024, Dr. Charnvitayapong wrote 1,794 Medicare Part D claims for 359 patients. 55% of them were for generic drugs. CMS names the drug for 1,596 of them, across 38 drugs with 11 or more claims each, at $761,601 in total drug cost. In 2023, CMS named 2,078 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Charnvitayapong for performance year 2024, reported as part of a group. Dr. Charnvitayapong accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Charnvitayapong.

CMS Open Payments shows 676 general payments to Dr. Charnvitayapong from 52 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,561.

Dmand AI lists 1 award for Dr. Charnvitayapong, most recently CMS Stage 1 EHR in 2013.

Dr. Charnvitayapong graduated from Creighton University School of Medicine - Omaha in 1990.

Dr. Charnvitayapong is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.